|This is the document namespace holder page for the PDF document file YS1.pdf, located on AIDS Wiki servers. This PDF file is NOT available under the GNU Free Documentation License.|
In its Fall 2001 issue, Yale Scientific published an article, “Imagining the Future of Science”, by undergraduate David Weinreb. This article profiled three Yale science professors and their efforts to “envision how their fields will be transformed in the twenty-first century.” One of these professors was William Prusoff, who is described as having “discovered that d4T, a failed cancer drug first synthesized in 1966, is effective in the treatment of AIDS.” The article describes the alliance between Yale and Bristol-Myers Squibb to manufacture d4T “after the compound was proven to be effective in a study of thousands of human test subjects.” The article also describes efforts to make the drug “widely available to African communities who otherwise would never have seen [sic] these drugs.” The section profiling Prusoff closes by quoting him saying, “Their [pharmaceutical companies'] profits are fantasic. Only the oil companies are doing better.”
Lang sumbitted a response to the Weinreb article for publication in Yale Scientific, which was rejected, citing a “current policy to publish only student-written material [sic].” Gordon Moran, Yale '60, writes Margaret Ebert, Editor-in-Chief of Yale Scientific, concluding that “such a reason represents a form of double standard, and is therefore suppression”, citing the fact that the original Weinreb article transmits faculty voices largely in interview form. Moran then writes Lang, citing extensive documentation on the toxicities of d4T. (23 pages)
NOTWITHSTANDING ANY OTHER NOTICE ON THIS PAGE, the material on this page is NOT available under the GNU Free Documentation License; in accordance with Title 17 U.S.C. section 107, it is posted in the manner of bulletin boards in schools and workplaces, to encourage public education and citizen awareness, without profit or payment, for persons and entities engaging in non-profit research and educational activities and purposes only.